PMID: 11319040Apr 25, 2001Paper

The evolving role of radical surgery in the management of regionally advanced transitional cell carcinoma of the bladder

The Canadian Journal of Urology
Armen G. Aprikian, Simon Tanguay

Abstract

The management of muscle-invasive transitional cell carcinoma (TCC) of the bladder continues to evolve. The standard treatment for patients presenting with clinical stage T2-4aN0M0 bladder cancer remains radical cystectomy. However, the management of patients who present with more advanced disease on clinical evaluation, such as unresectable pelvic tumor (T4b) or regional pelvic lymph node metastases (N+) remains unclear. In addition, the intraoperative management of unsuspected pelvic adenopathy identified during exploration of a planned radical cystectomy, continues to generate controversy. The following discussion relates to the evolving attitudes towards the role of surgery in the treatment of advanced bladder cancer.

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

The Canadian Journal of Urology
Roanne SegalCancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group
International Journal of Urology : Official Journal of the Japanese Urological Association
Giuseppe SimoneMichele Gallucci
Journal of the National Comprehensive Cancer Network : JNCCN
William C Huang, B H Bochner
Expert Opinion on Pharmacotherapy
Guru SonpavdeSeth P Lerner
© 2021 Meta ULC. All rights reserved